Semaglutide and Food Noise: A New Discovery New findings presented at the Annual Meeting of…
Browsing: Semaglutide
Semaglutide is a medication primarily used to treat type 2 diabetes and obesity. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the naturally occurring hormone GLP-1 to increase insulin secretion, reduce appetite, and slow down digestion. This helps in better blood sugar control and weight loss. Semaglutide is available in injectable forms and as an oral tablet, and it has been shown in clinical trials to be highly effective in improving glycemic control and aiding significant weight loss, making it a valuable option for managing these conditions.
A sweeping Danish study reveals a harsh truth about today’s most popular weight-loss drug: more…
Researchers warn that widespread use of weight-loss drugs like Ozempic among women of reproductive age…
Women between the ages of 50 and 64 use medications the most. Nearly 12% of…
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments…
Ozempic’s surge in popularity for weight loss has sparked new concerns over its potential effects…
Researchers have found a potential game-changing way to help people lose weight and control blood…
More than a billion people worldwide struggle with obesity, and popular treatments like Ozempic and…
Though GLP-1 drugs drive major weight loss, researchers warn they may fall short in improving…
Women and older adults using semaglutide, a popular anti-obesity medication, may face a heightened risk…
A major new study reveals that combining the weight-loss drug tirzepatide with menopause hormone therapy…
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight…
Scientists have discovered a specific set of brain cells responsible for the weight loss effects…
An international study reveals that the drug can reverse liver damage in patients. An international…
Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40%…
A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people…
Despite semaglutide’s popularity for weight loss, experts are sounding the alarm on its major shortcomings—limited…
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study…